KLAS Contact
Contact KLAS
Contact KLAS
2025 BEST IN KLAS
Preferences
Related Series
2023
2022
2021
2019
Related Segments
Drug Diversion Monitoring 2025
Which Vendors Are Most Effectively Detecting Drug Diversion?
Author
Jackson Tate
Author
Lance Merrell
Author
Maddie Calder
Surveyed healthcare organizations suspect that instances of drug diversion occur far more frequently than they are caught. Drug diversion monitoring solutions are vital for combating this issue, and although previous KLAS research indicates that recent AI developments show promise in enhancing detection and prevention, organizations are raising their expectations. They want solutions that integrate better, handle more-complex data sets, and identify diversion more frequently—especially across multiple departments. Still, secondary outcomes (see chart below) are making these solutions worthwhile in the short term as vendors work to meet organizations’ expectations. To understand the current state of the drug diversion monitoring market, this report examines vendor performance, the impact solutions have on drug diversion detection, and the secondary outcomes customers are realizing with their solutions.
If you don't have a login, getting started is easy.
Key Findings:
- Bluesight Customers Detect Diversion Frequently & Are Especially Confident Using Solution for Nursing; Protenus Customers Lean on CSMs to Drive Deeper Value
- BD Customers Identify Diversion Less Consistently; Imprivata’s* Upgrades Not Keeping Pace with the Market
- HelioMetrics’* Slow Adoption of New Technology Deters Current & Potential Customers; Wolters Kluwer* Solution Requires Intensive Manual Work
*Limited data
Writer
Sarah Brown
Designer
Kath Spencer
Project Manager
Andrew Wright
This material is copyrighted. Any organization gaining unauthorized access to this report will be liable to compensate KLAS for the full retail price. Please see the KLAS DATA USE POLICY for information regarding use of this report. © 2025 KLAS Research, LLC. All Rights Reserved. NOTE: Performance scores may change significantly when including newly interviewed provider organizations, especially when added to a smaller sample size like in emerging markets with a small number of live clients. The findings presented are not meant to be conclusive data for an entire client base.